The complaint alleges that Insulet failed to maintain adequate control over its manufacturing operations between February 21, 2025, and May 26, 2026. These systemic deficiencies reportedly created safety risks for customers, rendering the company’s public disclosures during this period materially misleading. The suit focuses on alleged breaches of Sections 10(b) and 20(a) of the Securities Exchange Act, as well as SEC Rule 10b-5.

Investors who incurred financial losses during the specified class period are being urged by the DJS Law Group to review their legal options. While the firm is actively seeking lead plaintiffs to head the litigation, participation in any eventual recovery does not mandate a formal lead plaintiff appointment. The DJS Law Group, led by David J. Schwartz, is currently coordinating outreach for affected shareholders to evaluate claims against the NASDAQ-listed firm.